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white matter microstructure in UK Biobank: a novel
approach to integrating genetics and
neuroimaging
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Mark J. Adams 1, Xueyi Shen1, Stephen M. Lawrie 1, Andrew M. McIntosh 1,5 and Heather C. Whalley 1
Abstract
Expression quantitative trait loci (eQTL) are genetic variants associated with gene expression. Using genome-wide
genotype data, it is now possible to impute gene expression using eQTL mapping efforts. This approach can be used
to analyse previously unexplored relationships between gene expression and heritable in vivo measures of human
brain structural connectivity. Using large-scale eQTL mapping studies, we computed 6457 gene expression scores
(eQTL scores) using genome-wide genotype data in UK Biobank, where each score represents a genetic proxy
measure of gene expression. These scores were then tested for associations with two diffusion tensor imaging
measures, fractional anisotropy (NFA= 14,518) and mean diffusivity (NMD= 14,485), representing white matter
structural integrity. We found FDR-corrected significant associations between 8 eQTL scores and structural connectivity
phenotypes, including global and regional measures (βabsolute FA= 0.0339–0.0453; MD= 0.0308–0.0381) and
individual tracts (βabsolute FA= 0.0320–0.0561; MD= 0.0295–0.0480). The loci within these eQTL scores have been
reported to regulate expression of genes involved in various brain-related processes and disorders, such as neurite
outgrowth and Parkinson’s disease (DCAKD, SLC35A4, SEC14L4, SRA1, NMT1, CPNE1, PLEKHM1, UBE3C). Our findings
indicate that eQTL scores are associated with measures of in vivo brain connectivity and provide novel information not
previously found by conventional genome-wide association studies. Although the role of expression of these genes
regarding white matter microstructural integrity is not yet clear, these results suggest it may be possible, in future, to
map potential trait- and disease-associated eQTL to in vivo brain connectivity and better understand the mechanisms
of psychiatric disorders and brain traits, and their associated imaging findings.
Introduction
Expression quantitative trait loci (eQTL) are genetic
variants which are proximally (cis) or distally (trans)
associated with variation in the expression of genes1.
Previous animal and human studies have found that
changes in gene expression lead to phenotypic variation,
including adaptive phenotypic changes and evolutionary
developments. In humans, for instance, cis-regulatory
mutations lead to differences in lactase (LCT) gene
expression, resulting in lactase persistence in adulthood2.
With respect to psychiatric disorders, major depressive
disorder (MDD) and bipolar disorder have been asso-
ciated with decreased expression of prodynorphin mes-
senger RNA (mRNA), which is involved in regulation of
mood and expressed in limbic-related areas within the
brain (e.g., amygdala, hippocampus)3–5. These findings
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indicate the importance of cis-regulatory mutations to
trait variance.
Variation in gene regulation leads to differences in
individual phenotypes, indicating that eQTL may play a
role in susceptibility to disease6,7. To test this hypothesis,
methods which combine gene expression data with
genome-wide association studies (GWAS) summary sta-
tistics have been developed. These approaches may pro-
vide further insight into the potential causal pathways and
genes involved in specific disorders, or predict the reg-
ulatory roles of single nucleotide polymorphisms (SNPs)
in linkage disequilibrium (LD) with previously associated
variants8. Previous studies have found that genetic varia-
tion may explain some of the variance in levels of gene
expression in human tissues, including post-mortem
brain tissue9–12. In one such study, Zou et al.13 con-
ducted an expression genome-wide association study
(eGWAS) on post-mortem brains of individuals with
Alzheimer’s disease (AD) and other brain pathologies
(non-AD; including progressive supranuclear palsy). They
found 2980 cisSNPs associated with both AD and non-AD
conditions. By investigating brain eQTL in post-mortem
tissue therefore, researchers have been able to discover
associations between gene expression and disease states in
the brain.
Using brain tissue in order to investigate gene expression
levels is however problematic, due to limitations such as
small sample sizes and possible expression level differences
in post-mortem versus ante-mortem brains14. As such,
alternative approaches have therefore been investigated.
One such approach is using eQTL measured from whole
blood gene expression as a proxy for brain gene expression;
an approach supported by important benefits such as
greater sample size and easier accessibility15. Although it is
recommended that wherever possible gene expression levels
should be measured in a tissue-specific manner, consider-
able overlap has been demonstrated between blood and
brain eQTL, supporting the validity of the approach14.
Neuroimaging measures provide a novel opportunity to
investigate whether eQTL are significantly associated with
in vivo brain phenotypes, and thereby increasing our
knowledge of the role of eQTL in the wider context of
psychiatric disorders. White matter microstructure, as
measured by diffusion tensor imaging (DTI), is con-
sistently heritable across tracts16–18 and is compromised
in several psychiatric disorders. Generally, decreased
microstructural integrity of white matter is characterised
by lower directionality of water molecule diffusion
(reduced fractional anisotropy, FA) and less constrained
water molecule diffusion (increased mean diffusivity,
MD). Consistent findings across studies have indicated
higher MD and lower FA in individuals suffering from
MDD, for example19,20. Investigating the regulatory loci
associated with white matter microstructure in health and
disease may aid in the detection of molecular mechanisms
influencing disease through aberrant structural brain
connectivity.
Within the current study, we derived eQTL scores
based on two well-powered whole-blood eQTL stu-
dies21,22. We then used GENOSCORES, a database of
filtered summary statistics of publicly-available GWAS
covering multiple phenotypes, including gene expression,
to calculate eQTL scores (https://pm2.phs.ed.ac.uk/
genoscores/).
The resultant eQTL-based genetic scores can be con-
sidered proxies for the expression of particular genes,
which can then be tested for association with traits of
interest. Here, we analysed their association with white
matter microstructure as measured by FA and MD in UK
Biobank. We used participants from the October 2018 UK
Biobank neuroimaging release (NFA= 14,518; NMD=
14,485). The purpose of the study was to utilise a novel
approach to investigate associations between regulatory
SNPs and white matter microstructure. This approach
could lead to further specialised investigation into psy-
chiatric and neurological disorders, as well as other brain-
related traits, such as cognition and behaviour.
Methods and materials
UK Biobank (UKB)
UK Biobank is a health resource aiming to prevent,
diagnose and treat numerous disorders. It is comprised of
502,617 individuals whose genetic and environmental
data (e.g., lifestyle, medications) were collected between
2006 and 2010 in the United Kingdom (http://www.
ukbiobank.ac.uk/). UKB received ethical approval from
the Research Ethics Committee (reference: 11/NW/0382).
This study has been approved by the UKB Access Com-
mittee (Project #4844). Written informed consent was
obtained from all participants.
Study population
In the current study, individuals were excluded if they
participated in studies such as the Psychiatric Genomics
Consortium (51; PGC) MDD GWAS or Generation
Scotland (52; Scottish Family Health Study), or if the
individuals were biologically related to another partici-
pant, to remove overlap of genetic samples. For the brain
imaging sample, a quality check performed by UK Bio-
bank ensured that no abnormal scans were included in
subsequent analyses23. We additionally excluded indivi-
duals whose global measures for FA and MD lay more
than three standard deviations from the sample mean19,24.
This resulted in 14,518 individuals with FA values
(Nfemale= 7561 (52%); Nmale= 6957 (48%); mean age:
63.14 ± 7.4; age range: 45.92–80.67) and 14,485 indivi-
duals with MD values (Nfemale= 7552 (52%); Nmale= 6933
(48%); mean age: 63.12 ± 7.39; age range: 45.92–80.67).
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Genotyping and eQTL score calculation
A total of 488,363 UKB blood samples (Nfemale= 264,857;
Nmale= 223,506; http://biobank.ctsu.ox.ac.uk/crystal/field.
cgi?id=22001) were genotyped using the UK BiLEVE array
(N= 49,949; http://biobank.ctsu.ox.ac.uk/crystal/refer.cgi?
id=149600) and the UK Biobank Axiom array (N= 438,417;
http://biobank.ctsu.ox.ac.uk/crystal/refer.cgi?id=149601).
Details of genotyping and quality control are described in
more detail by Hagenaars et al.25 and Bycroft et al.26.
From GENOSCORES, we used eQTL analysis summary
statistics from two studies of whole-blood eQTL21,22.
Briefly, Gusev et al.21 developed a novel approach aimed at
identifying associations between gene expression and
complex traits in cases where gene expression level is not
directly measured. These authors reported eQTL based on
a sample of 1414 individuals with whole-blood expression
measured using the Illumina HumanHT-12 version 4
Expression BeadChip. Westra et al.22 performed a large
eQTL meta-analysis in 5311 samples across 7 studies from
peripheral blood, with gene expression measured using
Illumina whole-genome Expression BeadChips (HT12v3,
HT12v4 or H8v2 arrays). Their aim was to investigate the
magnitude of the effect of cis and trans SNPs on gene
expression, as well as to observe whether mapping eQTL in
peripheral blood could uncover biological pathways asso-
ciated with complex traits and disease. Further details of
data acquisition and protocols are described in more detail
in the two studies21,22.
We computed a total of 10,884 eQTL scores (N Gusev
study= 3801; N Westra study= 7083) for individuals inclu-
ded in the imaging sample (NFA: 14,518; NMD: 14,485) from
the SNPs found in GENOSCORES, using a p-value threshold
of 1 × 10−5 (0.00001). We then excluded overlapping eQTL
scores between the two studies (i.e., scores for which SNPs
affect expression of the same gene in both studies) by only
including the score where a SNP had the lowest p-value, i.e.,
most significant association. The final eQTL score list was
6457 (NGusev study= 3286;NWestra study= 3171). These
scores were used as input variables in subsequent statistical
analyses. Figure S1 in Supplementary Materials provides a
summary of the score derivation process.
Briefly, eQTL scores were computed as a sum of the gen-
otypes for an individual (g, scored as 0, 1, 2 copies of the
reference allele) weighted by the effect size estimate (βt) for the
trait of interest t. In order to adjust for LD, vector βt was pre-
multiplied by the generalised inverse of the SNP-SNP corre-
lation matrix R estimated from the 1000 Genomes reference
panel, limited to the individuals with European ancestry.
The formula to compute the eQTL score for trait t for
an individual (i) is therefore:
score i; tð Þ ¼ giR1βt
Magnetic resonance imaging (MRI) acquisition
In the current study, imaging-derived phenotypes
(IDPs) produced by UKB were used. MRI acquisition and
pre-processing procedures for white matter tracts were
performed by UKB using standardised protocols (https://
biobank.ctsu.ox.ac.uk/crystal/docs/brain_mri.pdf). Briefly,
images were acquired in Manchester (NFA= 12,248;
NMD= 12,221) and Newcastle (NFA= 2270; NMD= 2264)
on a standard Siemens Skyra 3 T scanner with a 32-
channel radio-frequency (RF) receive head coil and later
pre-processed using the FMRIB Software Library (FSL),
and parcellation of white matter tracts was conducted
using AutoPtx23. Individual white matter tracts belonging
to each tract category can be observed in Table S1 in
Supplementary Materials.
Owing to the fact that head position and RF coil in the
scanner may affect data quality and subsequent pre-pro-
cessing, three scanner brain position variables were also
generated by UKB, with the aim of being used as con-
founding variables in subsequent analyses. These are lat-
eral brain position—X (http://biobank.ctsu.ox.ac.uk/
crystal/field.cgi?id= 25756), transverse brain position—Y
(http://biobank.ctsu.ox.ac.uk/crystal/field.cgi?id= 25757)
and longitudinal brain position—Z (http://biobank.ctsu.
ox.ac.uk/crystal/field.cgi?id= 25758). The three variables
were included as covariates in the statistical analysis
described below.
Statistical methods
All analyses were conducted using R (version 3.2.3) in
a Linux environment. The R code for the current
analyses is available in Supplementary Materials, sec-
tion 3. For each white matter tract, we used generalized
linear mixed models (function “lme” in package
“nlme”) for bilateral brain regions, which were included
as dependent variables. The eQTL scores were inclu-
ded as independent variables separately in each model,
with additional covariates: age, age2, sex, fifteen genetic
principal components to control for population stra-
tification, three MRI head position coordinates, MRI
site and genotype array, while hemisphere was included
as a within-subject variable. For unilateral tracts, as
well as global measures and white matter tract cate-
gories of FA and MD, also included in the models as
dependent variables, we used a general linear model
(function “lm”), using the same covariates as above,
without hemisphere included as a separate term, and
again including the eQTL scores as independent vari-
ables separately in each model.
For global measures and white matter tract categories of
FA and MD, we applied principal component analysis
(PCA) on the white matter tracts of interest (all 27 for
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global measures; 12 for association fibres; 6 for thalamic
radiations; 9 for projection fibres) in order to extract a
latent measure. Scores of the first unrotated component
were extracted and set as dependent variables in general
linear models. False discovery rate (FDR) correction using
the “p.adjust” function in R (q < 0.05) was applied across
the eQTL scores and the individual white matter tracts
(Ntests= 98,855), and separately across eQTL scores and
global and tract categories (Ntests= 25,828).
In addition, we included quadratic terms for each
eQTL score in linear models to test non-linear rela-
tionships between the eQTL scores and global and
regional measures of white matter microstructure.
Analyses included all covariates mentioned above, with
the only addition being the quadratic term of each eQTL
score included alongside the original score. Results
depicting the proportion of variance explained by the
quadratic terms are included in Tables S2–S3 and Figs.
S2–S3 in the Supplementary Materials.
Finally, for the top significant findings in the manu-
script, we ran linear models where there were overlapping
genes between the two discovery datasets21,22 (i.e. eQTL
scores that regulate the expression of the same gene in
both Gusev et al. and Westra et al.), and report results
from both datasets for comparison (Tables S4–S12 in
Supplementary Materials).
Results
There were several eQTL scores that showed sig-
nificant associations with a number of global measures,
tract categories, and white matter tracts post FDR cor-
rection (q < 0.05); Table 1; Figs. 1 (a, b) and 2 (a, b);
Tables S13–S20 in Supplementary Materials). In total,
25 scores were significantly associated with FA values
(βabsolute= 0.032–0.056) and 24 scores with MD values
(βabsolute= 0.029–0.048) in several tracts (see Tables
S21–S22 and Figs. S4–S5 in Supplementary Materials).
Among these scores, 8 were associated with white
matter tracts measured by both FA and MD. The pri-
mary findings reported in this manuscript focus on these
8 overlapping scores, as these were considered to pro-
vide the most consistent information with regards to
gene expression within white matter tracts as measured
by two different DTI scalars (see Tables 2 and 3), further
findings are presented in Tables S23–S24 in Supple-
mentary Materials.
The Allen Brain Atlas27 was used to investigate gene
expression patterns across brain regions in 6 donors.
Figs. S6–S8 and Table S25 in Supplementary Materials
provide a summary of each donor’s individual gene
expression level as well as a mean gene expression
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The effect of the 8 scores on FA measures of white matter
microstructure
Table 2.
The effect of the 8 scores on MD measures of white matter
microstructure
Table 3.
Genome-wide associations between score SNPs and white
matter tracts
Using a previously published GWAS of imaging traits28,
we next sought to observe the association between the
SNPs comprising each of the 8 scores (Ntotal= 53; SNP list
can be found in Table S26 in Supplementary Materials)
with those found previously for the white matter tracts of
interest (i.e., the tracts which showed post-FDR significant
associations). This SNP look-up was performed in order
to observe whether our analysis of eQTL scores, com-
prising SNPs which together regulate the expression of a
single gene, yielded any novel associations with white
matter tracts which were not previously found in
conventional GWAS.
We used the Brain Imaging Genetics (BIG) database
(http://big.stats.ox.ac.uk/) to extract the effect size and p-
value of each SNP of interest as associated with the white
matter tracts, as provided in Elliott et al.28. As GWAS for
Fig. 1 a, b Indicates nominal p-values between each of the 8 scores (shown in legend entitled “eQTL score”) and global and tract category measures
(noted on the x-axis; FA= fractional anisotropy (Fig. 1a); MD=mean diffusivity (Fig. 1b)). All values in the figure met FDR correction. Two of the
scores with an additional line around the points (CPNE1 and NMT1) had an effect size in the opposite direction to all other scores (also indicated by
-β for MD in figure legend). The colours of the plot points indicate the score to which they belong. Magnitude of effect is shown in the legend
entitled “Effect size (absolute value)”.
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global and tract category measures were not performed in
the original study28, we performed these GWAS as part of
the current project (i.e., GWAS for global measures,
association fibres, thalamic radiations and projection
fibres). Our GWAS parameters and quality check proce-
dures are described in more detail in Supplementary
Materials, section 11. p-Values and effect size of each SNP
for each individual white matter tract of interest (left and
right hemispheres separately from Elliott et al.28), as well
as for global and tract categories (run locally), are also
contained in Figure S9 in Supplementary Materials.
Briefly, only one SNP across three eQTL scores was
previously found to reach genome-wide significance with
forceps minor (FA)28, projection fibres (FA) and global FA
(GWAS run locally): rs2237077.
Discussion
In this study, we utilised a novel approach to investigate
whether eQTL scores corresponding to the expression of
specific genes in whole blood were significantly and spe-
cifically associated with white matter tracts in N > 14,000
individuals. We found significant associations in white
matter microstructure as measured by both FA and MD
for a number of scores (FAN scores= 25; MDN scores= 24).
Of these, 8 scores were found to be significantly asso-
ciated with various white matter tracts as measured by
Fig. 2 a, b Indicates nominal p-values between each of the 8 scores (shown in legend entitled “eQTL score”) and individual white matter tracts (noted
on the x-axis; FA= fractional anisotropy (Fig. 2a); MD=mean diffusivity (Fig. 2b); SLF= superior longitudinal fasciculus; ILF= inferior longitudinal
fasciculus; IFOF= inferior fronto-occipital fasciculus; ATR= anterior thalamic radiations; PTR= posterior thalamic radiations). All values in the figure
met FDR correction. Two of the scores with an additional line around the points (CPNE1 and NMT1) had an effect size in the opposite direction to all
other scores (+β and −β for FA and MD, respectively in figure legend). The colours of the plot points indicate the score to which they belong.
Magnitude of effect is shown in the legend entitled “Effect size (absolute value)”.
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Table 2 Significant associations between eQTL scores and global measures, category, and individual white matter tracts
(FA); FDR= false discovery rate; for each score, tracts are arranged from global to individual tracts.
Score, white matter tracts Effect size SD t-value p-value p-value, FDR corrected R2 (%)
DCAKD eQTL score
Global FA −0.037 0.008 −4.647 1.37 × 10−8 0.009 0.132
Thalamic radiations −0.040 0.008 −5.038 1.88 × 10–9 0.003 0.159
Superior longitudinal fasciculus −0.039 0.008 −5.033 4.89 × 10−7 0.004 0
Anterior thalamic radiations −0.043 0.008 −5.680 3.45 × 10−7 <0.001 0
Forceps minor −0.047 0.008 −6.012 1.07 × 10–5 <0.001 0.221
SLC35A4 eQTL score
Global FA −0.040 0.008 −5.100 1.12 × 10−5 0.002 0.156
Association fibres −0.035 0.008 −4.404 2.57 × 10−6 0.020 0.114
Projection fibres −0.045 0.008 5.761 1.15 × 10–5 <0.001 0.201
Corticospinal tract −0.033 0.007 −4.395 1.70 × 10−6 0.034 0
Acoustic radiation −0.033 0.007 −4.704 7.56 × 10−13 0.013 0
Inferior longitudinal fasciculus −0.034 0.008 −4.389 1.15 × 10−5 0.034 0
Superior longitudinal fasciculus −0.037 0.008 −4.789 1.05 × 10−7 0.010 0
Forceps minor −0.056 0.008 −7.175 5.60 × 10−6 <0.001 0.312
SEC14L4 eQTL score
Global FA −0.042 0.008 −5.320 1.28 × 10−7 0.001 0.167
Association fibres −0.036 0.008 −4.543 1.63 × 10−5 0.012 0.118
Thalamic radiations −0.039 0.008 −4.843 2.61 × 10−6 0.005 0.141
Projection fibres −0.042 0.008 5.285 3.19 × 10−7 0.001 0.167
Corticospinal tract −0.032 0.007 −4.312 4.39 × 10−8 0.042 0.842
Posterior thalamic radiation −0.035 0.008 −4.701 5.76 × 10−9 0.013 0.919
Superior longitudinal fasciculus −0.039 0.008 −5.114 3.19 × 10−7 0.003 0672
Inferior longitudinal fasciculus −0.042 0.008 −5.477 1.69 × 10−5 0.001 0.842
Forceps minor −0.046 0.008 −5.827 3.76 × 10−9 <0.001 0.200
SRA1 eQTL score
Projection fibres −0.034 0.008 4.303 1.83 × 10−5 0.027 0.109
Forceps minor −0.046 0.008 −5.898 6.99 × 10−6 <0.001 0.207
NMT1 eQTL score
Anterior thalamic radiations 0.032 0.008 4.286 1.58 × 10−5 0.043 0.162
Forceps minor 0.035 0.008 4.496 7.49 × 10−8 0.027 0.123
CPNE1 eQTL score
Forceps minor 0.034 0.008 4.319 9.40 × 10−6 0.042 0.108
Forceps major 0.044 0.008 5.382 7.49 × 10−8 0.001 0.181
PLEKHM1 eQTL score
Forceps minor −0.035 0.008 −4.432 1.37 × 10−8 0.034 0.119
UBE3C eQTL score
Forceps minor −0.038 0.008 −4.872 1.12 × 10−6 0.008 0.141
R2 represents variance explained (%) by each score for each tract.
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Table 3 Significant associations between eQTL scores and individual white matter tracts (MD); FDR= false discovery
rate; for each score, tracts are arranged from global to individual tracts.
Score, white matter tracts Effect size SD t-value p-value p-value, FDR corrected R2 (%)
DCAKD eQTL score
Global MD 0.040 0.008 5.376 7.72 × 10−8 0.002 0.166
Thalamic radiations 0.033 0.007 4.563 5.10 × 10−6 0.013 0.109
Association fibres 0.038 0.008 4.964 6.97 × 10−7 0.005 0.145
Acoustic radiation 0.030 0.007 4.247 2.18 × 10−5 0.047 0
Uncinate fasciculus 0.031 0.007 4.609 4.09 × 10−6 0.016 0
Cingulate gyrus 0.035 0.007 4.789 1.70 × 10−6 0.009 0
Inferior longitudinal fasciculus 0.038 0.007 5.177 2.29 × 10−7 0.002 0
Anterior thalamic radiations 0.040 0.007 5.796 6.92 × 10−9 <0.001 0
Inferior fronto-occipital fasciculus 0.041 0.008 5.481 4.31 × 10−8 0.001 0
Superior longitudinal fasciculus 0.042 0.008 5.490 4.08 × 10−8 0.001 0
Forceps minor 0.048 0.008 6.309 2.90 × 10−10 <0.001 0.232
SLC35A4 eQTL score
Global MD 0.031 0.008 4.089 4.35 × 10−5 0.042 0.088
Inferior longitudinal fasciculus 0.036 0.007 4.968 6.86 × 10−7 0.004 0
Forceps minor 0.043 0.008 5.677 1.39 × 10−8 <0.001 0181
SEC14L4 eQTL score
Global MD 0.033 0.008 4.330 1.50 × 10−5 0.028 0.094
Cingulate gyrus 0.033 0.007 4.465 8.07 × 10−6 0.025 0.593
Acoustic radiation 0.034 0.007 4.878 1.08 × 10−6 0.006 2.044
Forceps minor 0.035 0.008 4.560 5.15 × 10−6 0.019 0.110
SRA1 eQTL score
Forceps minor 0.035 0.008 4.635 3.60 × 10−6 0.016 0.116
NMT1 eQTL score
Global MD −0.033 0.008 −4.363 1.29 × 10−5 0.026 0.112
Inferior longitudinal fasciculus −0.031 0.007 −4.270 1.97 × 10−5 0.045 0.137
Inferior fronto-occipital fasciculus −0.034 0.008 −4.485 7.37 × 10−6 0.023 0.153
Anterior thalamic radiations −0.034 0.007 −4.870 1.13 × 10−6 0.006 0.110
Superior longitudinal fasciculus −0.034 0.008 −4.536 5.79 × 10−6 0.020 0.088
Forceps minor −0.039 0.008 −5.154 2.59 × 10−7 0.003 0.157
CPNE1 eQTL score
Global MD −0.037 0.008 −4.865 1.16 × 10−6 0.005 0.125
Association fibres −0.037 0.008 −4.787 1.71 × 10−6 0.006 0.126
Inferior longitudinal fasciculus −0.031 0.007 −4.230 2.35 × 10−5 0.050 0.249
Superior longitudinal fasciculus −0.036 0.008 −4.706 2.56 × 10−6 0.012 0.180
PLEKHM1 eQTL score
Global MD 0.033 0.008 4.386 1.16 × 10−5 0.025 0.112
Thalamic radiations 0.030 0.007 4.128 3.68 × 10−5 0.042 0.091
Association fibres 0.032 0.008 4.140 3.50 × 10−5 0.042 0.102
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both FA and MD. In particular, the largest effect was seen
for the association between forceps minor (FA) and the
eQTL score for SLC35A4, and across several tracts mea-
sured by MD for the eQTL score for DCAKD. Although
these eQTL were derived from whole blood, there is
evidence of expression in the brain for some of the genes,
outlined in further detail below. These findings also pro-
vided novel information not previously found by con-
ventional genome-wide association studies.
All 8 scores were associated with white matter micro-
structural integrity of the forceps minor as measured by
FA (7 of which were also associated with MD values). The
forceps minor forms the anterior part of the corpus cal-
losum, connecting homologous regions of the prefrontal
cortex between hemispheres. It is postulated to be
involved in numerous cognitive and behavioural skills,
such as decision making, social behaviour, and language29.
This connection therefore implicates forceps minor in a
wide range of cognitive skills, and damage to the tract has
been associated with neuropsychiatric and neurological
disorders, such as multiple sclerosis and depression30,31.
Global and individual tract findings—largest associations
The two genes with the largest associations were DCAKD,
globally and across numerous tracts as measured by higher
MD, and SCL35A4 across tracts measured by lower FA,
with a peak in projection fibres, localised to forceps minor.
DCAKD is a protein coding gene which is ubiquitously
expressed in brain, among other tissues32. Previous evi-
dence using mouse models indicates expression of this gene
has a putative role in neurodevelopment33, and is associated
with a number of psychiatric and neurological disorders,
including schizophrenia, autism spectrum disorder, and
Parkinson’s disease32,34,35. Evidence for involvement in
autism spectrum disorder comes from Butler et al.35, who
compiled a list of clinically relevant genes for the disorder,
with DCAKD among the participating susceptibility genes.
Expression of DCAKD was also found to be implicated in
Parkinson’s disease32, a disorder previously associated with
lower white matter integrity in tracts within the temporal,
parietal and occipital lobes36.
SLC35A4 belongs to the SLC35 family, members of
which act as transporters of nucleotide sugars, and is
known to be expressed in brain37. There is limited
knowledge about its specific function, although a recent
review investigating the subcellular localisation and
topology of SLC35A4 demonstrated that it localizes
mainly to the Golgi apparatus37.
Disease-linked genes—lower FA and higher MD
(decreased white matter integrity)
Four genes (SRA1, UBE3C, SEC14L4, PLEKHM1) were
associated with lower FA within several individual tracts
pertaining to projection and association fibres, as well as
with higher global MD. SRA1 encodes both non-coding
and protein-coding RNAs, is implicated in the regulation
of numerous nuclear receptor activities, such as metabo-
lism and chromatin organisation, and is known to be
expressed in the brain. Kotan et al.38 posited that SRA1
plays a role in the initiation of puberty in humans by
finding that inactivating SRA1 variants were associated
with idiopathic hypogonadotropic hypogonadism (IHH)
in three independent families. IHH is a rare genetic dis-
order caused by the inability of the hypothalamus to
secrete gonadotropin-releasing hormones (GnRH) or by
the inability of GnRH to act on pituitary gonadotropes39.
These previous results might link the association of SRA1
with projection fibres, which connect the cerebral cortex
to the spinal cord and brainstem, as well as to other
centres of the brain (e.g., thalamus).
UBE3C contains ubiquitin-protein ligase (E3), an
enzyme which accepts ubiquitin from E2 before trans-
ferring it to the target lysine; ubiquitin targets proteins for
degradation via the proteasome. UBE3C is expressed in
numerous tissues, including the brain, and has been
previously associated with some neuropsychiatric-related
phenotypes. For instance, Garriock et al.40 performed a
GWAS to determine the association between genetic
variation and Citalopram response. Although not
genome-wide significant, their top finding was a SNP in
proximity to UBE3C and was found to be associated with
antidepressant response and MDD remission (rs6966038,
Table 3 continued
Score, white matter tracts Effect size SD t-value p-value p-value, FDR corrected R2 (%)
Forceps minor 0.033 0.008 4.388 1.15 × 10−5 0.030 0.112
Superior longitudinal fasciculus 0.034 0.008 4.522 6.17 × 10−6 0.021 0
Anterior thalamic radiations 0.036 0.007 5.110 3.26 × 10−7 0.003 0
UBE3C eQTL score
Forceps minor 0.033 0.008 4.347 1.39 × 10−5 0.035 0.104
Inferior fronto-occipital fasciculus 0.033 0.008 4.441 9.01 × 10−6 0.027 0
R2 represents variance explained (%) by each score for each tract.
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p= 4.65e-07 and p= 3.63E-07, respectively)40. Moreover,
Filatova et al.41 studied the expression of genes within the
ubiquitin-proteasome protein degradation system, which
is implicated in Parkinson’s disease, in mice with MPTP-
induced pre-symptomatic and early symptomatic stages of
Parkinson’s disease. They found decreased expression in
the striatum and the substantia nigra of mice, which may
lead to a decrease in performance of the system. This may
in turn lead to accumulation of abnormal and toxic pro-
teins which guide neuronal cell death41.
The specific function of SEC14L4 has not yet been
determined, although the protein encoded by it is similar
to a protein encoded by the SEC14 gene in saccharomyces
cerevisiae, which is essential to the biogenesis of Golgi-
derived transport vesicles. Curwin and McMaster42 found
that mutations in several SEC14 domain-containing pro-
teins in humans may be implicated in neurodegeneration,
although it is not clear what the role of SEC14L4 is within
this context. Lastly, PLEKHM1 is important in bone
resorption, may be involved in vesicular transport in the
osteoclast, and is weakly expressed in the brain. Although
mutations in this gene have been associated with
numerous phenotypes43,44, none were neuropsychiatric-
related.
Development-linked genes—higher FA and lower MD
(increased white matter integrity)
For two of the eight genes (CPNE1, NMT1) we found
higher FA and lower MD, indicating increased white
matter integrity, associated with increased expression
level as quantified by the corresponding eQTL.
CPNE1, which is thought to regulate molecular events
at the cell membrane and cytoplasm, has previously been
found to mediate several neuronal differentiation pro-
cesses by interacting with intracellular signalling mole-
cules. CPNE1 has also been found to be highly expressed
during brain development, indicating that it might be
implicated in earlier developmental stages of neuronal
function45. Furthermore, C2 domains of CPNE1, calcium-
dependent phospholipid-binding motives, have been
shown to be implicated in neurite outgrowth of hippo-
campal progenitor HiB5 cells, which are hippocampal cell
lines derived from the hippocampal analgen of E16
rat46,47. We provide evidence that CPNE1 expression is
associated with two tracts within projection fibres (FA)
and with regional association fibres (MD), which link the
cortex to lower brain areas. In mouse and human models,
these findings may be of use when investigating neurite
outgrowth from the hippocampus, which is part of the
limbic system, an area located beneath the cortex.
NMT1 (N-myristoyltransferase) catalyzes the transfer of
myristate (a rare 14-carbon saturated fatty acid) from CoA
to proteins, and is expressed in numerous tissues,
including ubiquitously in the brain. It has been found that
NMT1 is required for early mouse development, mainly
due to its role in early embryogenesis48. Expression of this
gene has also been implicated in human brain tumours49
and tumour cell proliferation50. In our study, we found
NMT1 to be associated with tracts within thalamic
radiations and projection fibres (FA) and global MD.
General discussion
In our study, we employed a novel strategy of investi-
gating a direct association between eQTL scores and
white matter tracts to uncover a relationship between
specific regulatory variants and brain connectivity.
Together, our findings indicate that increases in expres-
sion of these genes may be implicated in several processes
which may directly or indirectly alter white matter
microstructure, each with localised, pronounced effects in
specific tracts. Further, while some of the significant
associations had connections with other brain-related
traits, such as neurite outgrowth or psychiatric and neu-
rological disorders, others did not. Interestingly,
decreased white matter microstructure integrity, as
marked by lower FA and higher MD, was associated with
eQTL scores which regulate expression of genes impli-
cated in neuropsychiatric and neurological disorders.
Conversely, increased white matter integrity, as marked
by higher FA and lower MD, was associated with CPNE1
and NMT1, which are important in developmental pro-
cesses such as neurite outgrowth. In addition, encoura-
gingly, regions of the corpus callosum (i.e., the forceps
minor), the largest and arguably most reliably measured
white matter tract in the brain, was demonstrated to be
associated with all 8 scores for FA, and 7 for MD. These
findings together suggest that utilising this approach to
associate eQTL scores with white matter microstructure
may add to previous research which found associations
between genes and these brain-related traits and dis-
orders. These genes or eQTL for them might indirectly
implicate brain connectivity through other processes in
which they participate.
The current study has several strengths and some
potential limitations. First, to our knowledge, this study is
the first one to compute eQTL scores for specific gene
transcripts and attempt to associate them with white
matter tracts. Moreover, our analysis consisted of a
population-based sample of N > 14,000 individuals
recruited to the UKB, large enough to make our findings
robust and generalisable to other samples within the same
age range, background and ethnicity. Lastly, our findings
revealed novel associations which were not previously
found in GWAS (28; GWAS of g measures run locally),
indicating a potential to use such scores for further dis-
covery analyses.
However, a potential limitation in this study is calcu-
lation of scores for data taken from whole blood.
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Although we note previous evidence indicates that whole
blood can be used as a proxy for brain eQTL, important
for study of in vivo brain traits14.
In summary, our results suggest that expression of the
genes discussed above alter white matter microstructure
and could facilitate the manifestation of numerous brain-
related traits. Uncovering specific markers leading to the
formation, maintenance and pathology of white matter
could enable downstream analyses to elucidate links
between genetics and neuroimaging in neurological and
psychiatric disorders, as well as other brain-related traits.
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